Supplementary Figure S2 from The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Supplementary Figure S2 shows ZN-c5 demonstrates minor agonist effect on uterine tissue A. Uterine wet weight change in juvenile rats treated with different doses of ZN-c5. B. H&E staining on uterine tissues after ZN-c5 treatment. Images were digitally scanned at 20X magnification
Fields of Study & Subjects
Estrogen and related hormone effects
Protein Degradation and Inhibitors
Advanced Breast Cancer Therapies
Publication details
- Publication date
- 2 April 2026
- Language
- EN